203 related articles for article (PubMed ID: 36891988)
21. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells.
Alissafi T; Hatzioannou A; Legaki AI; Varveri A; Verginis P
J Autoimmun; 2019 Nov; 104():102310. PubMed ID: 31421963
[TBL] [Abstract][Full Text] [Related]
22. Treg Therapies Revisited: Tolerance Beyond Deletion.
Pilat N; Sprent J
Front Immunol; 2020; 11():622810. PubMed ID: 33633742
[TBL] [Abstract][Full Text] [Related]
23. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies.
Nishikawa H; Koyama S
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34330764
[TBL] [Abstract][Full Text] [Related]
25. Targeting Treg cells in cancer immunotherapy.
Tanaka A; Sakaguchi S
Eur J Immunol; 2019 Aug; 49(8):1140-1146. PubMed ID: 31257581
[TBL] [Abstract][Full Text] [Related]
26. Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity.
Romano M; Fanelli G; Albany CJ; Giganti G; Lombardi G
Front Immunol; 2019; 10():43. PubMed ID: 30804926
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Nr4a Receptors Enhances Antitumor Immunity by Breaking Treg-Mediated Immune Tolerance.
Hibino S; Chikuma S; Kondo T; Ito M; Nakatsukasa H; Omata-Mise S; Yoshimura A
Cancer Res; 2018 Jun; 78(11):3027-3040. PubMed ID: 29559474
[TBL] [Abstract][Full Text] [Related]
28. Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Ohue Y; Nishikawa H
Cancer Sci; 2019 Jul; 110(7):2080-2089. PubMed ID: 31102428
[TBL] [Abstract][Full Text] [Related]
29. T cell metabolism in homeostasis and cancer immunity.
Wei J; Zheng W; Chapman NM; Geiger TL; Chi H
Curr Opin Biotechnol; 2021 Apr; 68():240-250. PubMed ID: 33676144
[TBL] [Abstract][Full Text] [Related]
30. Roles of regulatory T cells in cancer immunity.
Takeuchi Y; Nishikawa H
Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
[TBL] [Abstract][Full Text] [Related]
31. Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.
Selck C; Dominguez-Villar M
Front Immunol; 2021; 12():661875. PubMed ID: 34054826
[TBL] [Abstract][Full Text] [Related]
32. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.
Kumar P; Saini S; Khan S; Surendra Lele S; Prabhakar BS
Cell Immunol; 2019 May; 339():41-49. PubMed ID: 30482489
[TBL] [Abstract][Full Text] [Related]
33. Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.
Aristin Revilla S; Kranenburg O; Coffer PJ
Front Immunol; 2022; 13():903564. PubMed ID: 35874729
[TBL] [Abstract][Full Text] [Related]
34. Taking regulatory T-cell therapy one step further.
Sicard A; Boardman DA; Levings MK
Curr Opin Organ Transplant; 2018 Oct; 23(5):509-515. PubMed ID: 30063480
[TBL] [Abstract][Full Text] [Related]
35. TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy.
Li L; Liu X; Sanders KL; Edwards JL; Ye J; Si F; Gao A; Huang L; Hsueh EC; Ford DA; Hoft DF; Peng G
Cell Metab; 2019 Jan; 29(1):103-123.e5. PubMed ID: 30344014
[TBL] [Abstract][Full Text] [Related]
36. Human FOXP3
Wing JB; Tanaka A; Sakaguchi S
Immunity; 2019 Feb; 50(2):302-316. PubMed ID: 30784578
[TBL] [Abstract][Full Text] [Related]
37. Improving the Efficacy of Regulatory T Cell Therapy.
Baeten P; Van Zeebroeck L; Kleinewietfeld M; Hellings N; Broux B
Clin Rev Allergy Immunol; 2022 Apr; 62(2):363-381. PubMed ID: 34224053
[TBL] [Abstract][Full Text] [Related]
38. Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies.
Maharaj K; Uriepero A; Sahakian E; Pinilla-Ibarz J
Front Immunol; 2022; 13():943354. PubMed ID: 35979372
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression.
Gianchecchi E; Fierabracci A
Front Immunol; 2018; 9():2374. PubMed ID: 30386337
[TBL] [Abstract][Full Text] [Related]
40. Emerging Therapeutic Strategies to Restore Regulatory T Cell Control of Islet Autoimmunity in Type 1 Diabetes.
Volfson-Sedletsky V; Jones A; Hernandez-Escalante J; Dooms H
Front Immunol; 2021; 12():635767. PubMed ID: 33815387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
